Treatment Sequence Studied for Advanced BRAF-Mutant Melanoma

THURSDAY, Oct. 6, 2022 -- For patients with treatment-naive BRAFv600 mutant metastatic melanoma, treatment first with combination nivolumab/ipilimumab yields better overall survival than dual BRAF/MEK inhibition with dabrafenib/trametinib, according...